New Crohn's disease treatment trial now open to those in U.S.

Sunday, March 02, 2014 SPORK! 0 Comments

Qu Biologics has been testing an immunologic agent for treating Crohn's disease in Canada. Now clinical trials are available in the United States that uses Site Specific Immunomodulators (SSIs) for managing the form of IBD.

The biological pharmaceutical company reopened clinical trials in the U.S because of so much interest, "said Dr. Hal Gunn, M.D. in a press release.

According to the company, 30 U.S. patients will be accepted into Phase 1/2 clinical trials to investigate the safety and efficacy of QBECO SSI for Crohn's disease. The trial is located in Vancouver, Canada.

Read the full article at Exam Heath 

(http://www.emaxhealth.com/1020/new-crohns-disease-treatment-trial-now-open-those-us)